Adaptam Therapeutics
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
About
Adaptam Therapeutics is a biotechnology startup focused on discovering and developing new medicines for patients with rare genetic diseases. Their approach leverages cutting-edge protein degradation technologies to target the underlying causes of these conditions. The company aims to bring innovative therapies to market for previously untreatable diseases. Teams look it up for Biotech, Drug Discovery, Genomics.
Frequently asked
What does Adaptam Therapeutics do?
Adaptam Therapeutics is a Biotech company that offers Services. Teams look it up for Drug Discovery, Genomics, Rare Diseases. It is based in Cambridge, United States and was founded in 2021. Public records show about 6 people and $5M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Adaptam Therapeutics raised?
Adaptam Therapeutics has raised a total of $5M in funding. The most recent round on record is Seed.
Where is Adaptam Therapeutics headquartered?
Adaptam Therapeutics is headquartered in Cambridge, United States.
When was Adaptam Therapeutics founded?
Adaptam Therapeutics was founded in 2021.
What industry does Adaptam Therapeutics operate in?
Adaptam Therapeutics operates in Biotech, Drug Discovery, Genomics, Rare Diseases, Protein Degradation.
How many employees does Adaptam Therapeutics have?
Adaptam Therapeutics has approximately 6 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.